Reference SummaryZiegler CC, J Nutr 2004 Jan;134(1):5-10

Title

Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice.

Authors

Ziegler CC; Rainwater L; Whelan J; McEntee MF

Journal

J Nutr

Volume

134

Issue

1

Year

2004

Pages

5-10

Abstract

To determine its effect on intestinal tumorigenesis and the protumorigenic COX pathway in Apc(Min/+) mice, resveratrol was administered as a powdered admixture in the diet at 0, 4, 20, or 90 mg/kg body weight for 7 wk. In two separate experiments, resveratrol did not affect intestinal tumor load. It was stable in the diet under experimental conditions, circulated in the plasma as the glucuronide-conjugated form and reached the tumors as evidenced by significant decreases in PGE2 levels. However, immunohistochemical staining of intestinal tumors revealed no changes in COX-2 expression. This study demonstrates that resveratrol consumed ad libitum in the diet, does not modify tumorigenesis in Apc(Min/+) mice.

Links

J:88124 – MGI References
14704285 – National Library of Medicine/PubMed

Strain Notes

Strain Note
C57BL/6J-ApcMin/+ Purchased from The Jackson Laboratory.

Models

Strain Model Name Treatment Agent(s) Organ Affected Frequency Model Details
C57BL/6J-ApcMin/+ Intestine - Large Intestine tumor Intestine - Large Intestine

observed

C57BL/6J-ApcMin/+ Intestine - Large Intestine tumor
  • resveratrol
Intestine - Large Intestine

observed

C57BL/6J-ApcMin/+ Intestine - Small Intestine tumor Intestine - Small Intestine

observed

C57BL/6J-ApcMin/+ Intestine - Small Intestine tumor
  • resveratrol
Intestine - Small Intestine

observed